Wall Street analysts expect that Core Laboratories (NYSE:CLB) will announce earnings per share (EPS) of $0.50 for the current fiscal quarter, Zacks reports. Two analysts have provided estimates for Core Laboratories’ earnings. The lowest EPS estimate is $0.50 and the highest is $0.51. Core Laboratories reported earnings per share of $0.35 during the same quarter last year, which suggests a positive year-over-year growth rate of 42.9%. The business is expected to report its next quarterly earnings results on Wednesday, July 19th.

According to Zacks, analysts expect that Core Laboratories will report full-year earnings of $2.14 per share for the current year, with EPS estimates ranging from $1.94 to $2.40. For the next fiscal year, analysts forecast that the company will report earnings of $3.35 per share, with EPS estimates ranging from $2.51 to $4.10. Zacks Investment Research’s EPS averages are an average based on a survey of research firms that cover Core Laboratories.

Core Laboratories (NYSE:CLB) last posted its earnings results on Wednesday, April 19th. The oil and gas company reported $0.42 earnings per share for the quarter, topping analysts’ consensus estimates of $0.39 by $0.03. The business had revenue of $157.81 million for the quarter, compared to analyst estimates of $150.44 million. Core Laboratories had a return on equity of 65.65% and a net margin of 10.74%. The firm’s revenue was up 2.7% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.37 EPS.

A number of brokerages recently commented on CLB. Scotiabank set a $136.00 price target on Core Laboratories and gave the stock a “hold” rating in a report on Saturday, April 22nd. Tudor Pickering began coverage on Core Laboratories in a report on Thursday, March 23rd. They set a “hold” rating on the stock. Zacks Investment Research lowered Core Laboratories from a “hold” rating to a “sell” rating in a report on Tuesday, April 11th. ABN Amro upgraded Core Laboratories to a “hold” rating in a report on Friday, April 21st. Finally, Citigroup Inc reiterated a “neutral” rating and set a $117.00 price target (down from $119.00) on shares of Core Laboratories in a report on Saturday, March 11th. Two analysts have rated the stock with a sell rating, eight have issued a hold rating and three have assigned a buy rating to the company. The stock has a consensus rating of “Hold” and an average target price of $125.60.

A number of hedge funds have recently added to or reduced their stakes in CLB. Achmea Investment Management B.V. purchased a new stake in Core Laboratories during the first quarter worth about $245,000. Goldman Sachs Group Inc. increased its stake in Core Laboratories by 156.2% in the first quarter. Goldman Sachs Group Inc. now owns 68,823 shares of the oil and gas company’s stock worth $7,951,000 after buying an additional 41,955 shares in the last quarter. Ashford Capital Management Inc. increased its stake in Core Laboratories by 6.5% in the first quarter. Ashford Capital Management Inc. now owns 17,924 shares of the oil and gas company’s stock worth $2,071,000 after buying an additional 1,097 shares in the last quarter. FNY Managed Accounts LLC purchased a new stake in Core Laboratories during the first quarter worth about $123,000. Finally, HighTower Advisors LLC increased its stake in Core Laboratories by 155.4% in the first quarter. HighTower Advisors LLC now owns 9,579 shares of the oil and gas company’s stock worth $1,100,000 after buying an additional 5,829 shares in the last quarter.

Core Laboratories (NYSE:CLB) traded down 0.11% on Wednesday, hitting $106.98. The company had a trading volume of 86,083 shares. The stock has a market capitalization of $4.73 billion, a PE ratio of 70.85 and a beta of 1.55. The stock has a 50 day moving average of $111.37 and a 200-day moving average of $114.08. Core Laboratories has a one year low of $96.30 and a one year high of $133.38.

The company also recently announced a quarterly dividend, which was paid on Tuesday, May 23rd. Shareholders of record on Friday, April 28th were given a $0.55 dividend. This represents a $2.20 dividend on an annualized basis and a yield of 2.05%. The ex-dividend date of this dividend was Thursday, April 27th. Core Laboratories’s dividend payout ratio is currently 150.68%.

TRADEMARK VIOLATION NOTICE: This piece was posted by American Banking News and is owned by of American Banking News. If you are viewing this piece on another publication, it was illegally stolen and republished in violation of international trademark and copyright law. The correct version of this piece can be accessed at https://www.americanbankingnews.com/2017/05/24/core-laboratories-clb-expected-to-post-earnings-of-0-50-per-share.html.

Core Laboratories Company Profile

Core Laboratories N.V. provides reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company operates through three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples.

12 Month Chart for NYSE:CLB

Get a free copy of the Zacks research report on Core Laboratories (CLB)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Core Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.